Update on rituximab
Gespeichert in:
| Veröffentlicht in: | Annals of the rheumatic diseases 2005-11, Vol.64 (suppl 4), p.iv55-iv57 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | iv57 |
|---|---|
| container_issue | suppl 4 |
| container_start_page | iv55 |
| container_title | Annals of the rheumatic diseases |
| container_volume | 64 |
| creator | Eisenberg, R |
| description | |
| doi_str_mv | 10.1136/ard.2005.042648 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1766904</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008382201</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-aac44dd51561a881eb65ee82dfa4c2ba41dd2c783839ff0106ff064d7b9df4573</originalsourceid><addsrcrecordid>eNqFkM1LwzAYh4MoOqcnD95EED0I3fKd9CLI0CnKRJgiXkLapNrZtTNpZf73ZnTMj4uXhPA--fH-HgD2EewhRHhfO9PDELIepJhTuQY6iHIZYcjhOuhACElEYy62wLb3k_CEEslNsIU4JjGRcQfsPcyMru1hVR66vG7m-VQnO2Aj04W3u8u7Cx4uL8aDq-j2bng9OL-NEoZxHWmdUmoMQ4wjLSWyCWfWSmwyTVOcaIqMwamQRJI4yyCCPJycGpHEJqNMkC44a3NnTTK1JrVl7XShZi4s4T5VpXP1e1Lmr-ql-lBIcB5DGgJOlgGuem-sr9U096ktCl3aqvGKSwFjFLMAHv0BJ1XjylAuZAkhqQzaAtVvqdRV3jubrVZBUC10q6BbLXSrVnf4cfCzwTe_9BuA4yWgfaqLzOkyzf03JwiSmMHARS2X-9rOV3Pt3hQXRDA1ehyop3s2vHkejdWi-WnLJ9PJv1t-AYArox8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777848146</pqid></control><display><type>article</type><title>Update on rituximab</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Eisenberg, R</creator><creatorcontrib>Eisenberg, R</creatorcontrib><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2005.042648</identifier><identifier>PMID: 16239389</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>anti-TNF therapy ; Antibodies ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Autoimmune diseases ; Autoimmune Diseases - drug therapy ; B cells ; Biological and medical sciences ; chimeric monoclonal antibody ; Disease ; Diseases of the osteoarticular system ; Humans ; Immunomodulators ; Lupus ; Lymphoma ; Medical sciences ; Pharmacology. Drug treatments ; Purpura ; Randomized Controlled Trials as Topic ; Rheumatoid arthritis ; Rituximab ; Tetanus ; Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><ispartof>Annals of the rheumatic diseases, 2005-11, Vol.64 (suppl 4), p.iv55-iv57</ispartof><rights>Copyright 2005 by Annals of the Rheumatic Diseases</rights><rights>2006 INIST-CNRS</rights><rights>Copyright: 2005 Copyright 2005 by Annals of the Rheumatic Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-aac44dd51561a881eb65ee82dfa4c2ba41dd2c783839ff0106ff064d7b9df4573</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766904/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766904/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,309,310,314,727,780,784,789,790,885,23930,23931,25140,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17318250$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16239389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eisenberg, R</creatorcontrib><title>Update on rituximab</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><subject>anti-TNF therapy</subject><subject>Antibodies</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Autoimmune diseases</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>B cells</subject><subject>Biological and medical sciences</subject><subject>chimeric monoclonal antibody</subject><subject>Disease</subject><subject>Diseases of the osteoarticular system</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Lupus</subject><subject>Lymphoma</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Purpura</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Rheumatoid arthritis</subject><subject>Rituximab</subject><subject>Tetanus</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkM1LwzAYh4MoOqcnD95EED0I3fKd9CLI0CnKRJgiXkLapNrZtTNpZf73ZnTMj4uXhPA--fH-HgD2EewhRHhfO9PDELIepJhTuQY6iHIZYcjhOuhACElEYy62wLb3k_CEEslNsIU4JjGRcQfsPcyMru1hVR66vG7m-VQnO2Aj04W3u8u7Cx4uL8aDq-j2bng9OL-NEoZxHWmdUmoMQ4wjLSWyCWfWSmwyTVOcaIqMwamQRJI4yyCCPJycGpHEJqNMkC44a3NnTTK1JrVl7XShZi4s4T5VpXP1e1Lmr-ql-lBIcB5DGgJOlgGuem-sr9U096ktCl3aqvGKSwFjFLMAHv0BJ1XjylAuZAkhqQzaAtVvqdRV3jubrVZBUC10q6BbLXSrVnf4cfCzwTe_9BuA4yWgfaqLzOkyzf03JwiSmMHARS2X-9rOV3Pt3hQXRDA1ehyop3s2vHkejdWi-WnLJ9PJv1t-AYArox8</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>Eisenberg, R</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20051101</creationdate><title>Update on rituximab</title><author>Eisenberg, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-aac44dd51561a881eb65ee82dfa4c2ba41dd2c783839ff0106ff064d7b9df4573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>anti-TNF therapy</topic><topic>Antibodies</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Autoimmune diseases</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>B cells</topic><topic>Biological and medical sciences</topic><topic>chimeric monoclonal antibody</topic><topic>Disease</topic><topic>Diseases of the osteoarticular system</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Lupus</topic><topic>Lymphoma</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Purpura</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Rheumatoid arthritis</topic><topic>Rituximab</topic><topic>Tetanus</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eisenberg, R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eisenberg, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update on rituximab</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>64</volume><issue>suppl 4</issue><spage>iv55</spage><epage>iv57</epage><pages>iv55-iv57</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>16239389</pmid><doi>10.1136/ard.2005.042648</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4967 |
| ispartof | Annals of the rheumatic diseases, 2005-11, Vol.64 (suppl 4), p.iv55-iv57 |
| issn | 0003-4967 1468-2060 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1766904 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | anti-TNF therapy Antibodies Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Autoimmune diseases Autoimmune Diseases - drug therapy B cells Biological and medical sciences chimeric monoclonal antibody Disease Diseases of the osteoarticular system Humans Immunomodulators Lupus Lymphoma Medical sciences Pharmacology. Drug treatments Purpura Randomized Controlled Trials as Topic Rheumatoid arthritis Rituximab Tetanus Tumor Necrosis Factor-alpha - antagonists & inhibitors |
| title | Update on rituximab |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A00%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20on%20rituximab&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Eisenberg,%20R&rft.date=2005-11-01&rft.volume=64&rft.issue=suppl%204&rft.spage=iv55&rft.epage=iv57&rft.pages=iv55-iv57&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.2005.042648&rft_dat=%3Cproquest_pubme%3E4008382201%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777848146&rft_id=info:pmid/16239389&rfr_iscdi=true |